Last reviewed · How we verify
Paracetamol or oral NSAIDs excluding COX2 inhibitors — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Paracetamol or oral NSAIDs excluding COX2 inhibitors (Paracetamol or oral NSAIDs excluding COX2 inhibitors) — Bioiberica.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Paracetamol or oral NSAIDs excluding COX2 inhibitors TARGET | Paracetamol or oral NSAIDs excluding COX2 inhibitors | Bioiberica | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Paracetamol or oral NSAIDs excluding COX2 inhibitors CI watch — RSS
- Paracetamol or oral NSAIDs excluding COX2 inhibitors CI watch — Atom
- Paracetamol or oral NSAIDs excluding COX2 inhibitors CI watch — JSON
- Paracetamol or oral NSAIDs excluding COX2 inhibitors alone — RSS
Cite this brief
Drug Landscape (2026). Paracetamol or oral NSAIDs excluding COX2 inhibitors — Competitive Intelligence Brief. https://druglandscape.com/ci/paracetamol-or-oral-nsaids-excluding-cox2-inhibitors. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab